✦ LIBER ✦

Time for a low-risk DCIS trial: harnessing public and patient involvement

✍ Scribed by Lesley Fallowfield; Adele Francis; Susan Catt; Mairead Mackenzie; Valerie Jenkins

Book ID: 119609122
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 140 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70503-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concordance between vacuum assisted biop

Concordance between vacuum assisted biopsy and postoperative histology: Implications for the proposed Low Risk DCIS Trial (LORIS)

✍ Soumian, S.; Verghese, E.T.; Booth, M.; Sharma, N.; Chaudhri, S.; Bradley, S.; U 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Outpatient therapy with oral ofloxacin f

Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever : A prospective, randomized clinical trial

✍ Manuel Hidalgo; Javier Hornedo; Carlos Lumbreras; José M. Trigo; Ramón Colomer; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Background: Hospitalization and treatment with broad-spectrum intravenous antibiotics is the standard care for patients with neutropenia and fever. this randomized clinical trial evaluated the feasibility and efficacy of ambulatory care with oral ofloxacin for patients with low risk, chemotherap

A Phase II Trial of Real-time Target Tra

A Phase II Trial of Real-time Target Tracking SBRT for Low-risk Prostate Cancer Utilizing the Calypso 4D Localization System: Patient-reported Quality of Life and Toxicity Outcomes

✍ C.A. Mantz; E. Fernandez; I. Zucker; S. Harrison 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

1047 Chromoendoscopy Is Superior to Stan

1047 Chromoendoscopy Is Superior to Standard Surveillance Techniques for Both High and Low Risk Patients for the Detection of Dysplasia: Analysis of a Prospective Controlled Trial

✍ Jennifer Katz; Asher Kornbluth; James F. Marion; Jerome D. Waye; Daniel H. Prese 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

381 Split-Dosed MiraLAX® and Gatorade® I

381 Split-Dosed MiraLAX® and Gatorade® Is an Effective, Safe, and Tolerable Option for Bowel Preparation in Low Risk Patients: Results of a Randomized Controlled Trial

✍ Jason B. Samarasena; Mohammad U. Farukhi; V. Raman Muthusamy; M. Mazen Jamal 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Low Flow CO2-Cryotherapy for High Risk B

Low Flow CO2-Cryotherapy for High Risk Barrett's Esophagus (BE) Patients with High Grade Dysplasia and Early Adenocarcinoma: A Pilot Trial of Feasibility and Safety

✍ Marcia I. Canto; Kerry B. Dunbar; Patrick Okolo; Sanjay B. Jagannath; Sergey V. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB